About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug Reduces Fibrosis and Prevents DMD

by Bidita Debnath on December 11, 2017 at 11:43 PM
Font : A-A+

New Drug Reduces Fibrosis and Prevents DMD

Duchenne muscular dystrophy (DMD) is a fatal form of a muscle wasting disorder that is caused by mutations in a gene on the X chromosome. Researchers have found a new drug that reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of DMD.

The researchers from Saint Louis University (SLU) in the US, in a paper published in the Nature journal Scientific Reports, said this could provide a promising approach in designing new medications for those suffering from DMD.

Advertisement


With treatment, those with DMD have an average lifespan of around 25 years. Boys with the illness typically need to use a wheelchair by age 12 and require mechanical ventilation to help with breathing.

Many eventually suffer cardiac or respiratory failure.

Thomas Burris and Colin Flaveny from Saint Louis University aim to develop synthetic compounds to target these receptors in order to create drugs to treat diseases by understanding how the body's natural hormones operate.
Advertisement

"Recently, we found that REV-ERB appears to play unique roles for each stage of muscle tissue development," Flaveny said.

REV-ERB regulates key processes in the body, from sleep to cholesterol, and, most recently, muscle regeneration.

The team showed that REV-ERB is a regulator of muscle differentiation and that a drug that inhibits this receptor, called SR8278, stimulates muscle regeneration after acute injury.

The research team also discovered that SR8278 increased lean mass and muscle function and decreased muscle fibrosis and muscle protein degradation in mice.

"These results suggest that REV-ERB is a potent target for the treatment of DMD," Burris said. "This is an encouraging finding as we search for better treatments for those with this debilitating illness."

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity Drugs Banned in India Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

Recommended Reading
Health Insurance Aids in Treatment for Cystic Fibrosis
Improved access to medical care under the Medicaid Children's Health Insurance Program has an ......
New In-vitro Model to Help Develop Drugs for Cystic Fibrosis
A new laboratory model can be used to test new and existing therapeutics for cystic fibrosis, says ....
Molecular Pathway Identified That Could be a Therapeutic Target for Fibrosis
Newly identified pathway could be a therapeutic target for halting the fibrosis process and for ......
Prognosis of Myelofibrosis can Now be Predicted by a Genetic Model
A new genetic Model Has Now Been Identified To Predict the outcomes of Primary Myelofibrosis ......
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to e...
Retroperitoneal Fibrosis / Ormondīs Disease
Retroperitoneal fibrosis or Ormond's disease a rare disorder occurs when extra fibrous tissue forms ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use